Dashboard
Manage Tickers

ATR APTARGROUP, INC.

NYSE aptar.com


$ 129.00 $ 0.00 (0 %)    

Tuesday, 28-Oct-2025 09:32:39 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 630.57 $ 0.24 (0.04 %)
DIA $ 478.28 $ -0.52 (-0.11 %)
SPY $ 686.45 $ -0.58 (-0.08 %)
TLT $ 91.87 $ 0.05 (0.05 %)
GLD $ 361.50 $ -0.35 (-0.1 %)
$ 128.78
$ 129.14
$ 128.36 x 101
$ 129.45 x 28
-- - --
$ 127.38 - $ 175.85
521,664
na
8.48B
$ 0.80
$ 21.67
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2025 06-30-2025 10-Q
2 05-02-2025 03-31-2025 10-Q
3 02-07-2025 12-31-2024 10-K
4 10-25-2024 09-30-2024 10-Q
5 07-26-2024 06-30-2024 10-Q
6 04-26-2024 03-31-2024 10-Q
7 02-09-2024 12-31-2023 10-K
8 10-26-2023 09-30-2023 10-Q
9 07-28-2023 06-30-2023 10-Q
10 04-28-2023 03-31-2023 10-Q
11 02-17-2023 12-31-2022 10-K
12 10-28-2022 09-30-2022 10-Q
13 07-29-2022 06-30-2022 10-Q
14 04-29-2022 03-31-2022 10-Q
15 02-18-2022 12-31-2021 10-K
16 10-29-2021 09-30-2021 10-Q
17 07-30-2021 06-30-2021 10-Q
18 04-30-2021 03-31-2021 10-Q
19 02-19-2021 12-31-2020 10-K
20 10-30-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-01-2020 03-31-2020 10-Q
23 02-24-2020 12-31-2019 10-K
24 11-01-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-01-2019 03-31-2019 10-Q
27 02-21-2019 12-31-2018 10-K
28 11-05-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-03-2018 03-31-2018 10-Q
31 02-26-2018 12-31-2017 10-K
32 11-01-2017 09-30-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 05-01-2017 03-31-2017 10-Q
35 02-27-2017 12-31-2016 10-K
36 11-04-2016 09-30-2016 10-Q
37 08-01-2016 06-30-2016 10-Q
38 05-03-2016 03-31-2016 10-Q
39 02-25-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

aptar-digital-health-announces-fda-has-granted-510k-clearance-for-herotracker-sense
Aptar Digital Health Announces FDA Has Gra...
10/16/2025 12:11:50

Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U....

top-3-materials-stocks-that-may-rocket-higher-in-q3
Top 3 Materials Stocks That May Rocket Hig...
09/24/2025 12:22:06

aptargroup-increases-its-quarterly-dividend-from-045-to-048
AptarGroup Increases Its Quarterly Dividen...
09/08/2025 21:03:20

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies,...

this-hubspot-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday
This HubSpot Analyst Begins Coverage On A ...
09/04/2025 14:14:40

keybanc-initiates-coverage-on-aptargroup-with-overweight-rating-announces-price-target-of-220
Keybanc Initiates Coverage On AptarGroup w...
09/04/2025 09:42:05

Keybanc analyst Paul Knight initiates coverage on AptarGroup (NYSE:ATR) with a Overweight rating and announces Price Target ...

is-the-market-bullish-or-bearish-on-aptargroup
Is the Market Bullish or Bearish on AptarG...
08/27/2025 15:00:25

wells-fargo-maintains-overweight-on-aptargroup-lowers-price-target-to-153
Wells Fargo Maintains Overweight on AptarG...
08/04/2025 14:10:35

Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:ATR) with a Overweight and lowers the price target from $173 to $153.

raymond-james-maintains-outperform-on-aptargroup-lowers-price-target-to-172
Raymond James Maintains Outperform on Apta...
08/04/2025 13:22:27

Raymond James analyst Matt Roberts maintains AptarGroup (NYSE:ATR) with a Outperform and lowers the price target from $182 t...

aptargroup-sees-q3-adj-eps-153-161-vs-165-est
AptarGroup Sees Q3 Adj EPS $1.53-$1.61 vs ...
07/31/2025 21:02:03

AptarGroup (NYSE:ATR) is looking for Q3 Adj EPS of $1.53-$1.61 vs $1.65 analyst estimate..

aptargroup-q2-adj-eps-166-beats-157-estimate-sales-966009m-beat-954058m-estimate
AptarGroup Q2 Adj. EPS $1.66 Beats $1.57 E...
07/31/2025 21:00:58

AptarGroup (NYSE:ATR) reported quarterly earnings of $1.66 per share which beat the analyst consensus estimate of $1.57 by 5.87...

Core News & Articles
Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

what-to-expect-from-aptargroups-earnings
What to Expect from AptarGroup's Earnings
07/30/2025 16:01:36

how-do-investors-really-feel-about-aptargroup
How Do Investors Really Feel About AptarGr...
07/28/2025 19:00:30

atara-biotherapeutics-announces-fda-acceptance-and-priority-review-of-bla-for-tabelecleucel-in-epstein-barr-virus-positive-post-transplant-lymphoproliferative-disease
Atara Biotherapeutics Announces FDA Accept...
07/24/2025 12:04:16

aptargroup-says-its-nasal-drug-delivery-system-was-used-in-recently-published-brain-imaging-study-from-wake-forest-university-school-of-medicine
AptarGroup Says Its Nasal Drug Delivery Sy...
07/23/2025 12:30:48

Research by Wake Forest University School of Medicine provides a crucial method for future Alzheimer's disease treatment tr...

wells-fargo-maintains-overweight-on-aptargroup-raises-price-target-to-173
Wells Fargo Maintains Overweight on AptarG...
07/18/2025 19:23:15

Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:ATR) with a Overweight and raises the price target from $170 to $173.

aptargroups-aptar-pharma-acquires-the-clinical-trial-materials-manufacturing-capabilities-of-mod3-pharma-from-swk-holdings-terms-not-disclosed
AptarGroup's Aptar Pharma Acquires The Cli...
07/15/2025 21:03:55

Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announces its acquisit...

raymond-james-maintains-outperform-on-aptargroup-raises-price-target-to-182
Raymond James Maintains Outperform on Apta...
07/15/2025 16:01:17

Raymond James analyst Matt Roberts maintains AptarGroup (NYSE:ATR) with a Outperform and raises the price target from $175 t...

aptar-unveils-dual-active-material-science-technology-to-protect-sensitive-pharma-and-medical-devices-from-moisture-and-oxygen
Aptar Unveils Dual-Active Material Science...
07/08/2025 21:10:48

Dual-active material science solution is ideal for sensitive formulationsAptarGroup, Inc. (NYSE:ATR), a global leader in drug a...

looking-into-aptargroups-recent-short-interest
Looking Into AptarGroup's Recent Short Int...
07/07/2025 15:00:35

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION